[Tuftsin]
- PMID: 6209973
[Tuftsin]
Abstract
Literature review. The tetrapeptide tuftsin (Thr-Lys-Pro-Arg) is cleaved off the carrier IgG molecule enzymatically and stimulates the phagocytic and bactericidal activity of polymorphonuclear leucocytes and macrophages. The action of tuftsin is mediated by specific receptor sites on the surface of these cells. Its antitumor activity has been shown in vitro as well as in vivo. The influence of tuftsin on the major metabolic processes of the cell (hexosemonophosphate shunt; cAMP/cGMP; Ca++-distribution; redox reactions) is the basis of its mode of action.--The feature of tuftsin and its low toxicity make it a useful agent for immunotherapy.
Similar articles
-
In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.Methods Find Exp Clin Pharmacol. 1986 Feb;8(2):73-80. Methods Find Exp Clin Pharmacol. 1986. PMID: 2423822
-
Biochemical aspects of tuftsin deficiency syndrome.Med Biol. 1981 Jun;59(3):134-8. Med Biol. 1981. PMID: 6895538
-
Tuftsin: its chemistry, biology, and clinical potential.Crit Rev Biochem Mol Biol. 1989;24(1):1-40. doi: 10.3109/10409238909082550. Crit Rev Biochem Mol Biol. 1989. PMID: 2667894 Review.
-
Effects of tuftsin on postsplenectomy sepsis.Surgery. 1985 Jun;97(6):701-6. Surgery. 1985. PMID: 4002117
-
Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?Cancer Detect Prev Suppl. 1987;1:445-55. Cancer Detect Prev Suppl. 1987. PMID: 3319151 Review.